Similar articles

• Tofacitinib for rheumatoid arthritis.

  Gremese E, Ferraccioli G. Gremese E, et al. Lancet. 2013 May 25;381(9880):1812. doi: 10.1016/S0140-6736(13)61114-9. Lancet. 2013. PMID: 23706794 No abstract available.
• Tofacitinib for rheumatoid arthritis - Authors' reply.

  Burmester GR, Benda B, Gruben D, Bradley J, Mebus C. Burmester GR, et al. Lancet. 2013 May 25;381(9880):1812-3. doi: 10.1016/S0140-6736(13)61115-0. Lancet. 2013. PMID: 23706795 No abstract available.
• Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.

  Burmester GR, Blanco R, Charles-Schoeman C, Wollenhaupt J, Zerbini C, Benda B, Gruben D, Wallenstein G, Krishnaswami S, Zwillich SH, Koncz T, Soma K, Bradley J, Mebus C; ORAL Step investigators. Burmester GR, et al. Lancet. 2013 Feb 9;381(9865):451-60. doi: 10.1016/S0140-6736(12)61424-X. Epub 2013 Jan 5. Lancet. 2013. PMID: 23294500 Clinical Trial.
• [Tofacitinib for the treatment of rheumatoid arthritis].

  Tanaka Y. Tanaka Y. Nihon Rinsho. 2016 Jun;74(6):974-80. Nihon Rinsho. 2016. PMID: 27311188 Review. Japanese.
• Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies.

  Fleischmann R, Kremer J, Tanaka Y, Gruben D, Kanik K, Koncz T, Krishnaswami S, Wallenstein G, Wilkinson B, Zwillich SH, Keystone E. Fleischmann R, et al. Int J Rheum Dis. 2016 Dec;19(12):1216-1225. doi: 10.1111/1756-185X.12901. Epub 2016 Jul 25. Int J Rheum Dis. 2016. PMID: 27451980 Free PMC article. Review.